These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 38240870

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB, Schnadower D, Estes M, Casper TC, Goldstein SL, Grisaru S, Pavia AT, Wilfond BS, Metheney M, Kimball K, Tarr PI, Hyperhydration to Improve Kidney Outcomes in children with Shiga Toxin-producing E. Coli infection (HIKO-STEC) Study Team .
    Trials; 2023 May 27; 24(1):359. PubMed ID: 37245030
    [Abstract] [Full Text] [Related]

  • 3. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X, Ylinen E, Zhang J, Salmenlinna S, Halkilahti J, Saxen H, Narayanan A, Jahnukainen T, Matussek A.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0066022. PubMed ID: 35730965
    [Abstract] [Full Text] [Related]

  • 4. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
    Luna M, Kamariski M, Principi I, Bocanegra V, Vallés PG.
    Pediatr Nephrol; 2021 Jun 31; 36(6):1499-1509. PubMed ID: 33205220
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A.
    BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up.
    Rosales A, Kuppelwieser S, Giner T, Hofer J, Riedl Khursigara M, Orth-Höller D, Borena W, Cortina G, Jungraithmayr T, Würzner R, German-Austrian H. U. S.-Study Group.
    Pediatr Nephrol; 2024 Aug 13; 39(8):2459-2465. PubMed ID: 38589699
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network.
    J Pediatr; 2021 Oct 13; 237():34-40.e1. PubMed ID: 34197890
    [Abstract] [Full Text] [Related]

  • 14. Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement.
    Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T.
    Medicine (Baltimore); 2015 Jun 13; 94(24):e1000. PubMed ID: 26091445
    [Abstract] [Full Text] [Related]

  • 15. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.
    Doulgere J, Otto B, Nassour M, Wolters-Eisfeld G, Rohde H, Magnus T, Wagener C, Streichert T.
    BMJ Open; 2015 Mar 10; 5(3):e005659. PubMed ID: 25757942
    [Abstract] [Full Text] [Related]

  • 16. Prodromal Phase of Hemolytic Uremic Syndrome Related to Shiga Toxin-Producing Escherichia coli: The Wasted Time.
    Balestracci A, Meni Battaglia L, Toledo I, Martin SM, Alvarado C.
    Pediatr Emerg Care; 2021 Oct 01; 37(10):e625-e630. PubMed ID: 31290797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.
    Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, Humberg A, Benz K, Krause M, Pohl M, Liebau MC, Schild R, Lemke J, Beringer O, Müller D, Härtel C, Wigger M, Vester U, Konrad M, Haffner D, Pape L, Oh J, Kemper MJ.
    Clin Infect Dis; 2017 Jun 15; 64(12):1637-1643. PubMed ID: 28329394
    [Abstract] [Full Text] [Related]

  • 19. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA, Zhang C, Bard JE, Yergeau D, Halasa N, Gómez-Duarte OG.
    BMC Genomics; 2020 Aug 17; 21(1):564. PubMed ID: 32807093
    [Abstract] [Full Text] [Related]

  • 20. Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS).
    Loos S, Oh J, van de Loo L, Kemper MJ, Blohm M, Schild R.
    Pediatr Nephrol; 2021 Nov 17; 36(11):3777-3783. PubMed ID: 34046736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.